November 2017

Our final issue of 2017 has arrived. This issue covers partnering for CNS disorders, a development timeline of gene therapy events and advice on how to prepare for a pharmaceutical deal. The issue also includes companies actively working in these areas and seeking collaboration partners.  

About this edition

Read the full November issue here. The issue covers CNS disorders, gene therapy and pharmaceutical deal preparation.